NM_024589.3:c.532-2A>G
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_024589.3(ROGDI):c.532-2A>G variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,612,334 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_024589.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- amelocerebrohypohidrotic syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_024589.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ROGDI | NM_024589.3 | MANE Select | c.532-2A>G | splice_acceptor intron | N/A | NP_078865.1 | |||
| ROGDI | NR_046480.2 | n.539-2A>G | splice_acceptor intron | N/A |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ROGDI | ENST00000322048.12 | TSL:1 MANE Select | c.532-2A>G | splice_acceptor intron | N/A | ENSP00000322832.6 | |||
| ROGDI | ENST00000591392.5 | TSL:3 | c.460-2A>G | splice_acceptor intron | N/A | ENSP00000467509.1 | |||
| ROGDI | ENST00000586504.5 | TSL:5 | c.310-2A>G | splice_acceptor intron | N/A | ENSP00000465076.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152104Hom.: 0 Cov.: 33 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460230Hom.: 0 Cov.: 36 AF XY: 0.00 AC XY: 0AN XY: 726444 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152104Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74292 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Amelocerebrohypohidrotic syndrome Pathogenic:1
This sequence change affects an acceptor splice site in intron 7 of the ROGDI gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ROGDI are known to be pathogenic (PMID: 22424600, 23086778). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with Kohlschutter's syndrome (PMID: 22424600). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at